[Federal Register Volume 84, Number 141 (Tuesday, July 23, 2019)]
[Notices]
[Page 35446]
From the Federal Register Online via the Government Publishing Office [http://www.gpo.gov/]
[FR Doc No: 2019-15674]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meetings

TIME AND DATE: Notice is hereby given, pursuant to the provisions of
the Government in Sunshine Act, Public Law 94-409, that the Securities
and Exchange Commission Investor Advisory Committee will hold a meeting
on Thursday, July 25, 2019 at 9:00 a.m. (ET).

PLACE: The meeting will be held in Multi-Purpose Room LL-006 at the
Commission's headquarters, 100 F Street NE, Washington, DC 20549.

STATUS: This meeting will begin at 9:00 a.m. (ET) and will be open to
the public. Seating will be on a first-come, first-served basis. Doors
will open at 8:30 a.m. Visitors will be subject to security checks. The
meeting will be webcast on the Commission's website at http://www.sec.gov/.

MATTERS TO BE CONSIDERED: On July 3, 2019, the Commission issued notice
of the Committee meeting (Release No. 33-10658), indicating that the
meeting is open to the public (except during that portion of the
meeting reserved for an administrative work session during lunch), and
inviting the public to submit written comments to the Committee. This
Sunshine Act notice is being issued because a quorum of the Commission
may attend the meeting.
    The agenda for the meeting includes: Welcome remarks; a discussion
regarding regulation in areas with limited completion, a discussion
regarding trends in investment research (which may include a
recommendation from the Market Structure subcommittee); a discussion
regarding the proxy process (which may include a recommendation from
the Investor as Owner subcommittee); a presentation on the work of the
Office of the Advocate for Small Business Capital Formation; a
presentation on the work of the Office of Minority and Women Inclusion;
subcommittee reports; and a nonpublic administrative work session
during lunch.

CONTACT PERSON FOR MORE INFORMATION: For further information and to
ascertain what, if any, matters have been added, deleted or postponed;
please contact Vanessa A. Countryman from the Office of the Secretary
at<PHONE_NUMBER>.

    Dated: July 18, 2019.
Vanessa A. Countryman,
Secretary.
[FR Doc. 2019-15674 Filed 7-19-19; 11:15 am]
BILLING CODE 8011-01-P


[Federal Register: March 16, 2010 (Volume 75, Number 50)]
[Notices]
[Page 12555-12557]
[DOCID:fr16mr10-68]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0128]

Prescription Drug User Fee Act; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is announcing a public
meeting on the Prescription Drug User Fee Act (PDUFA). The legislative
authority for PDUFA expires in September 2012. At that time, new
legislation will be required for FDA to continue collecting user fees
for the prescription drug program. The Federal Food, Drug, and Cosmetic
Act (FD&C Act) requires that before FDA begins negotiations with the
regulated industry on PDUFA reauthorization, we publish a notice in the
Federal Register requesting public input on the reauthorization, hold a
public meeting at which the public may present its views on the
reauthorization, provide a period of 30 days after the public meeting
to obtain written comments from the public suggesting changes, and
publish the comments on FDA's Web site. FDA invites public comment on
the PDUFA program and suggestions regarding the features FDA should
propose for the next PDUFA program.

DATES:  The public meeting will be held on April 12, 2010, from 9 a.m.
to 5 p.m. Registration to attend the meeting must be received by April
5, 2010. See Section III.C of this document for information on how to
register for the meeting. Submit written or electronic comments by May
12, 2010.

ADDRESSES:  The meeting will be held at the Hilton Washington DC/
Rockville Hotel and Executive Meeting Center, 1750 Rockville Pike,
Rockville, MD 20852.
    Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061.
Rockville, MD 20852. Submit electronic comments to http://
www.regulations.gov. All comments should be identified with the docket
number found in brackets in the heading of this document.
    Transcripts of the meeting will be available for review at the
Division of Dockets Management and on the Internet at http://
www.regulations.gov approximately 30 days after the meeting.

FOR FURTHER INFORMATION CONTACT:  Mary Gross, Food and Drug
Administration, Center for Drug Evaluation and Research, 10903 New
Hampshire Ave., Bldg. 51, rm. 6178, Silver Spring, MD 20993, 301-796-
3519, FAX:<PHONE_NUMBER><EMAIL_ADDRESS>or
    Patrick Frey, Food and Drug Administration, Center for Drug
Evaluation and Research, 10903 New Hampshire Ave., Bldg. 51, rm. 6350,
Silver Spring, MD 20993,<PHONE_NUMBER>, FAX:<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Introduction

    FDA is announcing its intention to hold a public meeting on PDUFA.
The authority for PDUFA expires in September 2012. Without new
legislation, FDA will no longer be able to collect user fees to fund
the human drug review process. Section 736B(d)(2) (21 U.S.C. 379h-
2(d)(2)) of the FD&C Act requires that before FDA begins negotiations
with the regulated industry on PDUFA reauthorization, we do the
following: (1) Publish a notice in the Federal Register requesting
public input on the reauthorization, (2) hold a public meeting at which
the public may present its views on the reauthorization, (3) provide a
period of 30 days after the public meeting to obtain written comments
from the public suggesting changes, and (4) publish the comments on the
FDA Web site. This notice, the public meeting, the 30 day comment
period after the meeting, and the posting of the comments on the FDA
Web site will satisfy these requirements. The purpose of the meeting is
to hear stakeholder views on PDUFA as we consider the features to
propose in the next PDUFA program. FDA is interested in responses to
the following two general questions and welcomes any other pertinent
information stakeholders would like to share:
    1. What is your assessment of the overall performance of the PDUFA
IV program thus far?
    2. What aspects of PDUFA should be retained, changed, or
discontinued to further strengthen and improve the program?
    The following information is provided to help potential meeting
participants better understand the history and evolution of the PDUFA
program and its current status.

II. What is PDUFA? What Does It Do?

    PDUFA is a law that authorizes FDA to collect fees from drug
companies that submit marketing applications for certain human drug and
biological products. The original PDUFA (PDUFA I) was enacted in 1992
(as the Prescription Drug User Fee Act, Public Law 102-571) and had a
5-year life. In 1997, as PDUFA I expired, Congress passed the FDA
Modernization Act (FDAMA, Public Law 105-115) which included an
extension of PDUFA (PDUFA II) for an additional 5 years. In 2002,
Congress extended PDUFA again through fiscal year 2007 (PDUFA III)
through the Public Health Security and Bioterrorism Preparedness and
Response Act (Public Law 107-188). Most recently, Title I of the Food
and Drug Administration Amendments Act of 2007 (FDAAA, Public Law 110-
85) reauthorized PDUFA through fiscal year 2012 (PDUFA IV).
    PDUFA's intent has been to provide additional revenues so that FDA
could hire more staff, improve systems, and establish a better managed
human drug review process to make important therapies available to
patients sooner without compromising review quality or approval
standards. In conjunction with PDUFA, FDA agrees to certain performance
goals. These goals apply to

the process for the review of original new human drug and biological
product applications, resubmissions of original applications, and
supplements to approved applications. During the first few years of
PDUFA I, the additional funding enabled FDA to eliminate backlogs of
original applications and supplements. Phased in over the 5 years of
PDUFA I, the goals were to review and act on 90 percent of priority new
drug applications (NDAs), biologics license applications (BLAs), and
efficacy supplements within 6 months of submission of a complete
application; to review and act on 90 percent of nonpriority original
NDAs, BLAs, and efficacy supplements within 12 months; and on
resubmissions and manufacturing supplements within 6 months. Over the
course of PDUFA I, FDA exceeded all of these performance goals and
significantly reduced median review times of both priority and standard
NDAs and BLAs.
    Under PDUFA II, many of these review performance goals were
shortened and new procedural goals were added to improve FDA
interactions with industry sponsors and help facilitate the drug
development process. The procedural goals, for example, articulated
timeframes for scheduling sponsor-requested meetings intended to
address emerging drug development challenges, as well as timeframes for
the timely response to industry submitted questions on special study
protocols. FDA met or exceeded nearly all of the review and procedural
goals under PDUFA II. However, concerns grew that overworked review
teams often had to return applications as ``approvable'' as they did
not have the resources and sufficient staff time to work with the
sponsors to resolve issues so that applications could reach approval in
the first review cycle.
    A sound financial footing and support for limited postmarket risk
management were key themes of PDUFA III. Base user fee resources were
significantly increased and a mechanism to account for changes in human
drug review workload was adopted. PDUFA III also expanded the scope of
user fee activities to include postmarket surveillance of new therapies
for up to 3 years after marketing approval. FDA committed to the
development of guidance for industry on risk assessment, risk
management, and pharmacovigilance as well as guidance to review staff
and industry on Good Review Management Principles (GRMPs). Initiatives
to improve application submission and agency-sponsor interactions
during the drug development and application review processes were also
adopted.
    With PDUFA reauthorization under FDAAA Title I (PDUFA IV), FDA
obtained a significant increase in base fee funding and committed to
full implementation of GRMPs, which includes providing a planned review
timeline for premarket review, development of new guidance for industry
on innovative clinical trials, modernization of postmarket safety, and
elimination of the 3-year limitation on fee support for postmarket
surveillance. However, the passage of FDAAA Titles IV, V, and IX added
statutory requirements that increased the pre- and postmarket review
process requirements, added new deadlines, and effectively increased
the review workload. For example, these provisions significantly
increased the number of applications requiring advisory committee
review while creating more stringent conflict-of-interest rules for
advisory committee members. The provisions also provided expanded drug
safety authorities such as the authority to require Risk Evaluation
Mitigation Strategies (REMS), order safety labeling changes, and
require postmarket studies and trials. Since enactment of PDUFA IV at
the start of fiscal year 2008, FDA has focused on implementation of the
new statutory requirements, rapidly hiring new staff to increase FDA
review capacity, and the iterative improvement of review processes.
This necessary focus has affected performance on a number of PDUFA
review goals and delayed work on some of the new PDUFA IV initiatives.
    FDA has published a number of reports that may provide the public
with useful background on PDUFA IV and FDAAA. Key Federal Register
documents, PDUFA-related guidances, legislation, performance reports,
and financial reports and plans can be found at http://www.fda.gov/
ForIndustry/UserFees/PrescriptionDrugUserFee/default.htm. FDA will also
post a webinar on PDUFA to give the public more background information
on the program. The webinar will be available at http://www.fda.gov/
ForIndustry/UserFees/PrescriptionDrugUserFee/ucm117890.htm
approximately 10 days before the public meeting. FDAAA-specific
information is available at: http://www.fda.gov/RegulatoryInformation/
Legislation/FederalFoodDrugandCosmeticActFDCAct/
SignificantAmendmentstotheFDCAct/
FoodandDrugAdministrationAmendmentsActof2007/default.htm.

III. What Information Should You Know About the Meeting?

A. When and Where Will the Meeting Occur? What Format Will FDA Use?

    Through this notice, we are announcing a public meeting to hear
stakeholder views on what features we should propose in the PDUFA V
program. We will conduct the meeting on April 12, 2010, at the Hilton
Washington DC/Rockville (see ADDRESSES). In general, the meeting format
will include presentations by FDA and a series of panels representing
different stakeholder interest groups (such as patient advocates,
consumer protection, industry, health professionals, and academic
researchers). We will also provide an opportunity for individuals to
make presentations at the meeting and for organizations and individuals
to submit written comments to the docket after the meeting. FDA policy
issues are beyond the scope of these reauthorization discussions.
Accordingly, the presentations should focus on process enhancements and
funding issues, and not focus on policy issues.

B. What Questions Would FDA Like the Public to Consider?

    Please consider the following questions for this meeting:
    1. What is your assessment of the overall performance of the PDUFA
IV program thus far?
    2. What aspects of PDUFA should be retained, changed, or
discontinued to further strengthen and improve the program?

C. How Do You Register for the Meeting or Submit Comments?

    If you wish to attend and/or present at the meeting, please
register by e-mail to<EMAIL_ADDRESS>by April 5,
2010. Your e-mail should contain complete contact information for each
attendee, including name, title, affiliation, address, e-mail address,
and phone number. Registration is free and will be on a first-come,
first-served basis. Early registration is recommended because seating
is limited. FDA may limit the number of participants from each
organization based on space limitations. Registrants will receive
confirmation once they have been accepted. Onsite registration on the
day of the meeting will be based on space availability. We will try to
accommodate all persons who wish to make a presentation. The time
allotted for presentations may depend on the number of persons who wish
to speak. If you need special accommodations because of disability,
please contact

Mary Gross (see FOR FURTHER INFORMATION CONTACT) at least 7 days before
the meeting.
    In addition, any person may submit written or electronic comments
to the Division of Dockets Management (see ADDRESSES). Submit a single
copy of electronic comments or two paper copies of any mailed comments,
except that individuals may submit one paper copy. Comments are to be
identified with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday. To ensure
consideration, all comments must be received by May 12, 2010.

D. Will Meeting Transcripts Be Available?

    Please be advised that as soon as a transcript is available, it
will be accessible at http://www.regulations.gov and http://
www.fda.gov. It may be viewed at the Division of Dockets Management
(see ADDRESSES). A transcript will also be available in either hard
copy or on CD-ROM, after submission of a Freedom of Information
request. Written requests are to be sent to Division of Freedom of
Information (HFI-35), Office of Management Programs, Food and Drug
Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD 20857.

    Dated: March 11, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-5664 Filed 3-15-10; 8:45 am]
BILLING CODE 4160-01-S


[Federal Register Volume 83, Number 9 (Friday, January 12, 2018)]
[Notices]
[Page 1612]
[FR Doc No: 2018-00471]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL 9972-91-Region 2]

Proposed CERCLA Cost Recovery Settlement for Operable Unit Two of
the Diamond Alkali Superfund Site, In or About Essex and Hudson
Counties, New Jersey

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice; request for public comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Comprehensive Environmental Response,
Compensation, and Liability Act of 1980, as amended (``CERCLA''),
notice is hereby given by the U.S. Environmental Protection Agency
(``EPA''), Region 2, of a proposed cost recovery settlement agreement
pursuant to CERCLA, between the EPA and 15 settling parties (``Settling
Parties'') regarding Operable Unit Two of the Diamond Alkali Superfund
Site (``Site''), located in or about Essex and Hudson Counties, New
Jersey. Pursuant to the proposed cost recovery settlement agreement,
each Settling Party shall pay to EPA $280,600.00 to resolve the
Settling Party's civil liability under sections 106 and 107(a) of
CERCLA, related to Operable Unit Two of the Site.

DATES: Comments must be submitted on or before February 12, 2018.

ADDRESSES: The proposed settlement agreement is available for public
inspection at EPA's Region 2 offices. To request a copy of the proposed
settlement agreement, please contact the EPA employee identified in the
FOR FURTHER INFORMATION CONTACT section below.

FOR FURTHER INFORMATION CONTACT: Juan M. Fajardo, Assistant Regional
Counsel, Office of Regional Counsel, U.S. Environmental Protection
Agency Region 2, 290 Broadway--17th Floor, New York, NY 10007. Email:
[email protected] Telephone:<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: For 30 days following the date of
publication of this notice, EPA will receive written comments
concerning the proposed cost recovery settlement agreement. Comments to
the proposed settlement agreement should reference Operable Unit Two of
the Diamond Alkali Superfund Site, Index No. CERCLA-02-2017-2023. EPA
will consider all comments received during the 30-day public comment
period and may modify or withdraw its consent to the settlement
agreement if comments received disclose facts or considerations that
indicate that the proposed settlement agreement is inappropriate,
improper, or inadequate. EPA's response to comments will be available
for public inspection at EPA's Region 2 offices located at 290
Broadway, New York, NY 10007-1866.

    Dated: November 21, 2017.
Walter Mugdan,
Director, Emergency and Remedial Response Division. U.S. Environmental
Protection Agency, Region 2.
[FR Doc. 2018-00471 Filed 1-11-18; 8:45 am]
BILLING CODE 6560-50-P


1 MEMORANDUM SUBJECT: Meeting Minutes for the June 20, 2006 Meeting Between the US Environmental Protection Agency ( EPA) and the American Petroleum Institute to Discuss Development of a Web based Program to locate Urban Area Boundaries Relative to Glycol Dehydrators in the Oil and Natural Gas Production Industry FROM: Greg Nizich U. S. EPA.

TO: Air and Radiation Docket Docket No. EPA HQ OAR 2004 0238 DATE: June 23, 2006 The EPA held a conference call with the American Petroleum Institute ( API) , Advanced Resources International and BP on June 20, 2006 to discuss development of an online tool that could determine the distance between urban area boundaries and glycol dehydrators. The following people participated in the call:

Greg Nizich, EPA Stephanie Meadows, API KC Hustvedt, EPA Robin Petrusak, ARI Michael Godec, ARI Jeff Adams, BP The following topics were discussed:

1. The urban boundaries to be used   urbanized areas and urban clusters defined by the Census Bureau. 2. The need for the tool to be readily available to both industry and EPA personnel. 3. The reporting requirements necessary for sources to show they are beyond the distance within which emissions controls would be required. 4. Possible use of tool to help refine impacts estimate if ready before promulgation.


[Federal Register Volume 86, Number 137 (Wednesday, July 21, 2021)]
[Notices]
[Pages 38524-38525]
[FR Doc No: 2021-15430]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[SEC File No. 270-544, OMB Control No. 3235-0604]

Submission for OMB Review; Comment Request

Upon Written Request Copies Available From: Securities and Exchange
Commission, Office of FOIA Services, 100 F Street NE, Washington, DC
20549-2736

Extension:
    Form 10-D

    Notice is hereby given that, pursuant to the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange
Commission (``Commission'') has submitted to the Office of Management
and Budget this request for extension of the previously approved
collection of information discussed below.
    Form 10-D is a periodic report used by asset-backed issuers to file
distribution and pool performance information pursuant to Rule 13a-17
(17 CFR 240.13a-17) or Rule 15d-17 (17 CFR 240.15d-17) of the
Securities Exchange Act of 1934 (``Exchange Act'') (15 U.S.C. 78a et
seq.). The form is required to be filed within 15 days after each
required distribution date on the asset-backed securities, as specified
in

the governing documents for such securities. The information provided
by Form 10-D is mandatory and all information is made available to the
public upon request. Form 10-D takes approximately 39.0 hours per
response to prepare and is filed by approximately 8,258 respondents. We
estimate that 75% of the 39.0 hours per response (29.25 hours) is
prepared by the company for a total annual reporting burden of 241,547
hours (29.25 hours per response x 8,258 responses).
    An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid control number.
    The public may view background documentation for this information
collection at the following website: www.reginfo.gov. Find this
particular information collection by selecting ``Currently under 30-day
Review--Open for Public Comments'' or by using the search function.
Written comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
to (i) www.reginfo.gov/public/do/PRAMain and (ii) David Bottom,
Director/Chief Information Officer, Securities and Exchange Commission,
c/o Cynthia Roscoe, 100 F Street NE, Washington, DC 20549, or by
sending an email to<EMAIL_ADDRESS>
    Dated: July 14, 2021.
J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2021-15430 Filed 7-20-21; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 79, Number 154 (Monday, August 11, 2014)]
[Notices]
[Page 46799]
[FR Doc No: 2014-18900]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[ER-FRL-9016-4]

Environmental Impact Statements; Notice of Availability

    Responsible Agency: Office of Federal Activities, General
Information<PHONE_NUMBER> or http://www.epa.gov/compliance/nepa/.

Weekly receipt of Environmental Impact Statements
Filed 07/28/2014 Through 08/01/2014
Pursuant to 40 CFR 1506.9.

Notice

    Section 309(a) of the Clean Air Act requires that EPA make public
its comments on EISs issued by other Federal agencies. EPA's comment
letters on EISs are available at: http://www.epa.gov/compliance/nepa/eisdata.html.

SUPPLEMENTARY INFORMATION: The document listed below was inadvertently
omitted from EPA's Notice of Availability of EISs published in the
Federal Register on Friday, August 8, 2014.

EIS No. 20140220, Draft EIS, APHIS, 00, Determinations of Nonregulated
Status for Dicamba-Resistant Soybean and Cotton Varieties, Monsanto
Petitions (10-188-01p and 12-185-01p), Comment Period Ends: 09/25/2014,
Contact: Sid Abel<PHONE_NUMBER>.

    Dated: August 6, 2014.
Dawn Roberts,
Management Analyst, NEPA Compliance Division, Office of Federal
Activities.
[FR Doc. 2014-18900 Filed 8-8-14; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 86, Number 151 (Tuesday, August 10, 2021)]
[Notices]
[Pages 43651-43652]
[FR Doc No: 2021-16990]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 3063-000]

Blackstone Hydro Associates; Notice of Authorization for
Continued Project Operation

    On July 31, 2019, Blackstone Hydro Associates, licensee for the
Central Falls Hydroelectric Project No. 3063, filed an Application for
a Subsequent License pursuant to the Federal Power Act (FPA) and the
Commission's regulations thereunder. The Central Falls Hydroelectric
Project is located on the Blackstone River, in the City of Central
Falls, Providence County, Rhode Island.
    The license for Project No. 3063 was issued for a period ending
July 31, 2021. Section 15(a)(1) of the FPA, 16 U.S.C. 808(a)(1),
requires the Commission, at the expiration of a license term, to issue
from year-to-year an annual license to the then licensee(s) under the
terms and conditions of the prior license until a new license is
issued, or the project is otherwise disposed of as provided in section
15 or any other applicable section of the FPA. If the project's prior
license waived the applicability of section 15 of the FPA, then, based
on section 9(b) of the Administrative Procedure Act, 5 U.S.C. 558(c),
and as set forth at 18 CFR 16.21(a), if the licensee of such project
has filed an application for a subsequent license, the licensee may
continue to operate the

project in accordance with the terms and conditions of the license
after the minor or minor part license expires, until the Commission
acts on its application. If the licensee of such a project has not
filed an application for a subsequent license, then it may be required,
pursuant to 18 CFR 16.21(b), to continue project operations until the
Commission issues someone else a license for the project or otherwise
orders disposition of the project.
    If the project is subject to section 15 of the FPA, notice is
hereby given that an annual license for Project No. 3063 is issued to
Blackstone Hydro Associates for a period effective August 1, 2021
through July 31, 2022 or until the issuance of a new license for the
project or other disposition under the FPA, whichever comes first. If
issuance of a new license (or other disposition) does not take place on
or before July 31, 2022, notice is hereby given that, pursuant to 18
CFR 16.18(c), an annual license under section 15(a)(1) of the FPA is
renewed automatically without further order or notice by the
Commission, unless the Commission orders otherwise.
    If the project is not subject to section 15 of the FPA, notice is
hereby given that Blackstone Hydro Associates is authorized to continue
operation of the Central Falls Hydroelectric Project, until such time
as the Commission acts on its application for a subsequent license.

    Dated: August 4, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021-16990 Filed 8-9-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 88, Number 186 (Wednesday, September 27, 2023)]
[Notices]
[Pages 66446-66447]
[FR Doc No: 2023-21112]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-11420-01-OW]

Notice of Public Meeting of the Environmental Financial Advisory
Board (EFAB) With Webcast

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) announces a public
meeting with a webcast of the Environmental Financial Advisory Board
(EFAB). The meeting will be shared in real-time via webcast and public
comments may be provided in writing in advance or virtually via
webcast. Please see SUPPLEMENTARY INFORMATION for further details. The
purpose of the meeting will be for the EFAB to discuss possible future
advisory charges, provide updates on previous EFAB deliverables, and to
understand and consider environmental finance issues in the Great Lakes
region and Michigan. The meeting will be conducted in a hybrid format
of in-person and virtual via webcast.

DATES: The meeting will be held on:
    1. October 24, 2023, from 9 a.m. to 4 p.m. eastern time; and
    2. October 25, 2023, from 9 a.m. to 12 p.m. eastern time.

ADDRESSES:
    In-Person: Doubletree by Hilton Ann Arbor North, 3600 Plymouth
Road, Ann Arbor, Michigan 48105.
    Webcast: Information to access the webcast will be provided upon
registration in advance of the meeting.

FOR FURTHER INFORMATION CONTACT: Any member of the public who wants
information about the meeting may contact Tara Johnson via telephone/
voicemail at<PHONE_NUMBER> or email to [email protected]. General
information concerning the EFAB is available at www.epa.gov/waterfinancecenter/efab.

SUPPLEMENTARY INFORMATION:
    Background: The EFAB is an EPA advisory committee chartered under
the Federal Advisory Committee Act (FACA), 5 U.S.C. app. 2, to provide
advice and recommendations to EPA on innovative approaches to funding
environmental programs, projects, and activities. Administrative
support for the EFAB is provided by the Water Infrastructure and
Resiliency Finance Center within EPA's Office of Water. Pursuant to
FACA and EPA policy, notice is hereby given that the EFAB will hold a
public meeting with a webcast for the following purposes:
    (1) Discuss potential future EFAB charges;
    (2) Provide updates on recent EFAB deliverables; and
    (3) Receive briefings on environmental finance issues in the Great
Lakes region and Michigan.
    Registration for the Meeting: To register for the meeting, please
visit www.epa.gov/waterfinancecenter/efab#meeting. Interested persons
who wish to attend the meeting must register by October 18, 2023, to
attend in person or by October 20, 2023, to attend via webcast. Pre-
registration is strongly encouraged. In the event the meeting cannot be
held, an announcement will be made on the EFAB website at www.epa.gov/waterfinancecenter/efab and all registered attendees will be notified.
    Availability of Meeting Materials: Meeting materials, including the

meeting agenda and briefing materials, will be available on EPA's
website at www.epa.gov/waterfinancecenter/efab.
    Procedures for Providing Public Input: Public comment for
consideration by EPA's Federal advisory committees has a different
purpose from public comment provided to EPA program offices. Therefore,
the process for submitting comments to a Federal advisory committee is
different from the process used to submit comments to an EPA program
office. Federal advisory committees provide independent advice to EPA.
Members of the public may submit comments on matters being considered
by the EFAB for consideration as the Board develops its advice and
recommendations to EPA.
    Oral Statements: In general, individuals or groups requesting an
oral presentation at a public meeting will be limited to three minutes
each. Persons interested in providing oral statements at the October
2023 meeting should register in advance and provide notification, as
noted in the registration confirmation, by October 18, 2023, to be
placed on the list of registered speakers.
    Written Statements: Written statements should be received by
October 16, 2023, so that the information can be made available to the
EFAB for its consideration prior to the meeting. Written statements
should be sent via email to [email protected]. Members of the public should
be aware that their personal contact information, if included in any
written comments, may be posted to the EFAB website. Copyrighted
material will not be posted without explicit permission of the
copyright holder.
    Accessibility: For information on access or services for
individuals with disabilities or to request accommodations for a
disability, please register for the meeting and list any special
requirements or accommodations needed on the registration form at least
10 business days prior to the meeting to allow as much time as possible
to process your request.

Andrew D. Sawyers,
Director, Office of Wastewater Management, Office of Water.
[FR Doc. 2023-21112 Filed 9-26-23; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 88, Number 91 (Thursday, May 11, 2023)]
[Rules and Regulations]
[Pages 30225-30226]
[FR Doc No: 2023-10044]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 97

[Docket No. 31484; Amdt. No. 4058]

Standard Instrument Approach Procedures, and Takeoff Minimums and
Obstacle Departure Procedures; Miscellaneous Amendments

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This rule amends, suspends, or removes Standard Instrument
Approach Procedures (SIAPs) and associated Takeoff Minimums and
Obstacle Departure Procedures for operations at certain airports. These
regulatory actions are needed because of the adoption of new or revised
criteria, or because of changes occurring in the National Airspace
System, such as the commissioning of new navigational facilities,
adding new obstacles, or changing air traffic requirements. These
changes are designed to provide for the safe and efficient use of the
navigable airspace and to promote safe flight operations under
instrument flight rules at the affected airports.

DATES: This rule is effective May 11, 2023. The compliance date for
each SIAP, associated Takeoff Minimums, and ODP is specified in the
amendatory provisions.
    The incorporation by reference of certain publications listed in
the regulations is approved by the Director of the Federal Register as
of May 11, 2023.

ADDRESSES: Availability of matter incorporated by reference in the
amendment is as follows:

For Examination

    1. U.S. Department of Transportation, Docket Ops-M30, 1200 New
Jersey Avenue SE, West Bldg., Ground Floor, Washington, DC 20590-0001;
    2. The FAA Air Traffic Organization Service Area in which the
affected airport is located;
    3. The office of Aeronautical Information Services, 6500 South
MacArthur Blvd., Oklahoma City, OK 73169 or,
    4. The National Archives and Records Administration (NARA).
    For information on the availability of this material at NARA, email
[email protected] or go to: https://www.archives.gov/federal-register/cfr/ibr-locations.html.

Availability

    All SIAPs and Takeoff Minimums and ODPs are available online free
of charge. Visit the National Flight Data Center online at nfdc.faa.gov
to register. Additionally, individual SIAP and Takeoff Minimums and ODP
copies may be obtained from the FAA Air Traffic Organization Service
Area in which the affected airport is located.

FOR FURTHER INFORMATION CONTACT: Thomas J. Nichols, Flight Procedures
and Airspace Group, Flight Technologies and Procedures Division, Flight
Standards Service, Federal Aviation Administration. Mailing Address:
FAA Mike Monroney Aeronautical Center, Flight Procedures and Airspace
Group, 6500 South MacArthur Blvd., STB Annex, Bldg. 26, Room 217,
Oklahoma City, OK 73099. Telephone:<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: This rule amends 14 CFR part 97 by amending
the referenced SIAPs. The complete regulatory description of each SIAP
is listed on the appropriate FAA Form 8260, as modified by the National
Flight Data Center (NFDC)/Permanent Notice to Airmen (P-NOTAM), and is
incorporated by reference under 5 U.S.C. 552(a), 1 CFR part 51, and 14
CFR 97.20. The large number of SIAPs, their complex nature, and the
need for a special format make their verbatim publication in the
Federal Register expensive and impractical. Further, airmen do not use
the regulatory text of the SIAPs, but refer to their graphic depiction
on charts printed by publishers of aeronautical materials. Thus, the
advantages of incorporation by reference are realized and publication
of the complete description of each SIAP contained on FAA form
documents is unnecessary. This amendment provides the affected CFR
sections, and specifies the SIAPs and Takeoff Minimums and ODPs with
their applicable effective dates. This amendment also identifies the
airport and its location, the procedure and the amendment number.

Availability and Summary of Material Incorporated by Reference

    The material incorporated by reference is publicly available as
listed in the ADDRESSES section.
    The material incorporated by reference describes SIAPs, Takeoff
Minimums and ODPs as identified in the amendatory language for Part 97
of this final rule.

The Rule

    This amendment to 14 CFR part 97 is effective upon publication of
each separate SIAP and Takeoff Minimums and ODP as amended in the
transmittal. For safety and timeliness of change considerations, this
amendment incorporates only specific changes contained for each SIAP
and Takeoff Minimums and ODP as modified by FDC permanent NOTAMs.
    The SIAPs and Takeoff Minimums and ODPs, as modified by FDC
permanent NOTAM, and contained in this amendment are based on criteria
contained in the U.S. Standard for Terminal Instrument Procedures
(TERPS). In developing these changes to SIAPs and Takeoff Minimums and
ODPs, the TERPS criteria were applied only to specific conditions
existing at the affected airports. All SIAP amendments in this rule
have been previously issued by the FAA in a FDC NOTAM as an emergency
action of immediate flight safety relating directly to published
aeronautical charts.
    The circumstances that created the need for these SIAP and Takeoff
Minimums and ODP amendments require making them effective in less than
30 days.
    Because of the close and immediate relationship between these
SIAPs, Takeoff Minimums and ODPs, and safety in air commerce, I find
that notice and public procedure under 5 U.S.C. 553(b) are
impracticable and contrary to the public interest and, where
applicable, under 5 U.S.C. 553(d), good cause exists for making these
SIAPs effective in less than 30 days.
    The FAA has determined that this regulation only involves an
established body of technical regulations for which frequent and
routine amendments are necessary to keep them operationally current.
It, therefore--(1) is not a ``significant regulatory action'' under
Executive Order 12866; (2) is not a ``significant rule'' under DOT
regulatory Policies and Procedures (44 FR 11034; February 26, 1979);
and (3) does not warrant preparation of a regulatory evaluation as the
anticipated impact is so minimal. For the same reason, the FAA
certifies that this amendment will not have a significant economic
impact on a substantial number of small entities under the criteria of
the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 97

    Air traffic control, Airports, Incorporation by reference,
Navigation (air).

    Issued in Washington, DC, on April 14, 2023.
Thomas J. Nichols,
Aviation Safety, Flight Standards Service, Manager, Standards Section,
Flight Procedures & Airspace Group, Flight Technologies & Procedures
Division.

Adoption of the Amendment

    Accordingly, pursuant to the authority delegated to me, 14 CFR part
97 is amended by amending Standard Instrument Approach Procedures and
Takeoff Minimums and ODPs, effective at 0901 UTC on the dates
specified, as follows:

PART 97--STANDARD INSTRUMENT APPROACH PROCEDURES

0
1. The authority citation for part 97 continues to read as follows:

    Authority: 49 U.S.C. 106(f), 106(g), 40103, 40106, 40113, 40114,
40120, 44502, 44514, 44701, 44719, 44721-44722.

0
2. Part 97 is amended to read as follows:
    By amending: Sec.  97.23 VOR, VOR/DME, VOR or TACAN, and VOR/DME or
TACAN; Sec.  97.25 LOC, LOC/DME, LDA, LDA/DME, SDF, SDF/DME; Sec.
97.27 NDB, NDB/DME; Sec.  97.29 ILS, ILS/DME, MLS, MLS/DME, MLS/RNAV;
Sec.  97.31 RADAR SIAPs; Sec.  97.33 RNAV SIAPs; and Sec.  97.35 COPTER
SIAPs, Identified as follows:

* * * Effective Upon Publication

--------------------------------------------------------------------------------------------------------------------------------------------------------
      AIRAC date           State              City                 Airport          FDC No.      FDC date                      Subject
--------------------------------------------------------------------------------------------------------------------------------------------------------
18-May-23............  MI             Traverse City.......  Cherry Capital......       3/3643      3/30/23  RNAV (GPS) RWY 28, Orig-A.
18-May-23............  MI             Traverse City.......  Cherry Capital......       3/3645      3/30/23  RNAV (GPS) RWY 36, Orig-A.
18-May-23............  MI             Traverse City.......  Cherry Capital......       3/3647      3/30/23  VOR-A, Amdt 21.
--------------------------------------------------------------------------------------------------------------------------------------------------------

[FR Doc. 2023-10044 Filed 5-10-23; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 83, Number 213 (Friday, November 2, 2018)]
[Notices]
[Page 55210]
[FR Doc No: 2018-24071]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meetings

TIME AND DATE: 1:30 p.m. on Tuesday, November 6, 2018.

PLACE: The meeting will be held at the Commission's headquarters, 100 F
Street, NE, Washington, DC 20549.

STATUS: This meeting will be closed to the public.

MATTERS TO BE CONSIDERED: Commissioners, Counsel to the Commissioners,
the Secretary to the Commission, and recording secretaries will attend
the closed meeting. Certain staff members who have an interest in the
matters also may be present.
    The General Counsel of the Commission, or his designee, has
certified that, in his opinion, one or more of the exemptions set forth
in 5 U.S.C. 552b(c)(3), (5), (6), (7), (8), 9(B) and (10) and 17 CFR
200.402(a)(3), (a)(5), (a)(6), (a)(7), (a)(8), (a)(9)(ii) and (a)(10),
permit consideration of the scheduled matters at the closed meeting.
    Commissioner Roisman, as duty officer, voted to consider the items
listed for the closed meeting in closed session.
    The subject matters of the closed meeting will be:
    Institution and settlement of injunctive actions;
    Institution and settlement of administrative proceedings; and
    Other matters relating to enforcement proceedings.
    At times, changes in Commission priorities require alterations in
the scheduling of meeting items.

CONTACT PERSON FOR MORE INFORMATION: For further information and to
ascertain what, if any, matters have been added, deleted or postponed;
please contact Brent J. Fields from the Office of the Secretary at
(202) 551-5400.

    Dated: October 30, 2018.
Brent J. Fields,
Secretary.
[FR Doc. 2018-24071 Filed 10-31-18; 11:15 am]
 BILLING CODE 8011-01-P


[Federal Register Volume 86, Number 77 (Friday, April 23, 2021)]
[Notices]
[Pages 21790-21792]
[FR Doc No: 2021-08447]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

[Docket No. NHTSA-2020-0121; Notice 1]

FCA US LLC, Receipt of Petition for Decision of Inconsequential
Noncompliance

AGENCY: National Highway Traffic Safety Administration (NHTSA),
Department of Transportation (DOT).

ACTION: Receipt of petition.

-----------------------------------------------------------------------

SUMMARY: FCA US LLC (f/k/a Chrysler Group LLC) (``FCA US'') has
determined that certain model year (MY) 2017-2020 Dodge Charger Pursuit
motor vehicles with Officer Protection Package (``OPP'') modules do not
fully comply with Federal Motor Vehicle Safety Standard (FMVSS) No.
102, Transmission Shift Position Sequence, Starter Interlock, and
Transmission Braking Effect and FMVSS No. 118, Power-Operated Window,
Partition, and Roof Panel Systems. FCA US filed a noncompliance report
dated November 13, 2020, and subsequently petitioned NHTSA on December
4, 2020, for a decision that the subject noncompliance is
inconsequential as it relates to motor vehicle safety. This notice
announces receipt of FCA US's petition.

DATES: Send comments on or before May 24, 2021.

ADDRESSES: Interested persons are invited to submit written data,
views, and arguments on this petition. Comments must refer to the
docket and notice number cited in the title of this notice and
submitted by any of the following methods:
     Mail: Send comments by mail addressed to the U.S.
Department of Transportation, Docket Operations, M-30, West Building
Ground Floor, Room W12-140, 1200 New Jersey Avenue SE, Washington, DC
20590.
     Hand Delivery: Deliver comments by hand to the U.S.
Department of Transportation, Docket Operations, M-30, West Building
Ground Floor, Room W12-140, 1200 New Jersey Avenue SE, Washington, DC
20590. The Docket Section is open on weekdays from 10 a.m. to 5 p.m.
except for Federal holidays.
     Electronically: Submit comments electronically by logging
onto the Federal Docket Management System (FDMS) website at https://www.regulations.gov/. Follow the online instructions for submitting
comments.
     Comments may also be faxed to<PHONE_NUMBER>.
    Comments must be written in the English language and be no greater
than 15 pages in length, although there is no limit to the length of
necessary attachments to the comments. If comments are submitted in
hard copy form, please ensure that two copies are provided. If you wish
to receive confirmation that comments you have submitted by mail were
received, please enclose a stamped, self-addressed postcard with the
comments. Note that all comments received will be posted without change
to https://www.regulations.gov, including any personal information
provided.
    All comments and supporting materials received before the close of
business on the closing date indicated above will be filed in the
docket and will be considered. All comments and supporting materials
received after the closing date will also be filed and will be
considered to the fullest extent possible.
    When the petition is granted or denied, notice of the decision will
also be published in the Federal Register pursuant to the authority
indicated at the end of this notice.
    All comments, background documentation, and supporting materials
submitted to the docket may be viewed by anyone at the address and
times given above. The documents may also be viewed on the internet at
https://www.regulations.gov by following the online instructions for
accessing the docket. The docket ID number for this petition is shown
in the heading of this notice.
    DOT's complete Privacy Act Statement is available for review in a
Federal Register notice published on April 11, 2000 (65 FR 19477-78).

FOR FURTHER INFORMATION CONTACT: Frederick Smith, Compliance Engineer,
NHTSA, Office of Vehicle Safety Compliance,<PHONE_NUMBER> or Ahmad
Barnes, Compliance Engineer, NHTSA, Office of Vehicle Safety
Compliance,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:
    I. Overview: FCA US has determined that certain MY 2017-2020 Dodge
Charger Pursuit motor vehicles with OPP modules do not fully comply
with the requirements of paragraph S<IP_ADDRESS> of FMVSS No. 102,
Transmission Shift Position Sequence, Starter Interlock, and
Transmission Braking Effect (49 CFR 571.102) and paragraph S5.1 of
FMVSS No. 118, Power-Operated Window, Partition, and Roof Panel Systems
(49 CFR 571.118). FCA US filed a noncompliance report dated November
13, 2020, pursuant to 49 CFR part 573, Defect and Noncompliance
Responsibility and Reports. FCA US subsequently petitioned NHTSA on
December 4, 2020, for an exemption from the notification and remedy
requirements of 49 U.S.C. Chapter 301 on the basis that this
noncompliance is inconsequential as it relates to motor vehicle safety,
pursuant to 49 U.S.C. 30118(d) and 30120(h) and 49 CFR part 556,
Exemption for Inconsequential Defect or Noncompliance.
    This notice of receipt of FCA US's petition is published under 49
U.S.C. 30118 and 30120 and does not represent any Agency decision or
other exercise of judgment concerning the merits of the petition.
    II. Vehicles Involved: Approximately 27,593 MY 2017-2020 Dodge
Charger Pursuit motor vehicles with OPP modules, manufactured between
October 17, 2016, and October 30, 2020, are potentially involved.
    III. Noncompliance: FCA US explains that the noncompliance is
occurs when the OPP module is in Surveillance Mode, the subject
vehicles' PRNDL display will indicate the vehicle is in the REVERSE
``R'' position while the transmission is actually in the PARK ``P''
position and, therefore, do not fully meet the requirements specified
in paragraph S<IP_ADDRESS> of FMVSS No. 102. Additionally, when Surveillance
Mode is activated, the driver and passenger power-operated windows in
the subject

vehicles will only stop but do not reverse direction in the event that
an obstruction is detected and, therefore, does not fully meet the
requirements specified in S5.1 of FMVSS No. 118.
    IV. Rule Requirements: Paragraph S<IP_ADDRESS> of FMVSS No. 102 and
paragraph S5.1 of FMVSS No. 118 include the requirements relevant to
this petition. Except as specified in paragraph S<IP_ADDRESS> of FMVSS No.
102, if the transmission shift position sequence includes a park
position, identification of shift positions, including the positions in
relation to each other and the position selected, shall be displayed in
view of the driver whenever any of the following conditions exist (a)
the ignition is in a position where the transmission can be shifted, or
(b) the transmission is not in park. While closing, the power-operated
window, partition, or roof panel shall stop and reverse direction
either before contacting a test rod with properties described in
paragraphs S8.2 or S8.3 of FMVSS No. 118, or before exerting a
squeezing force of 100 newtons (N) or more on a semi-rigid cylindrical
test rod with the properties described in paragraph S8.1 when such test
rod is placed through the window partition, or roof panel opening at
any location in the manner described in the applicable test under
paragraph S7.
    V. Summary of FCA US's Petition: The following views and arguments
presented in this section, ``V. Summary of FCA US's Petition,'' are the
views and arguments provided by FCA US. They have not been evaluated by
the Agency and do not reflect the views of the Agency. FCA US describes
the subject noncompliances and contends that the noncompliances are
inconsequential as they relate to motor vehicle safety.
    In support of its petition, FCA US submitted the following
reasoning:
    1. Functionality of the Officer Protection Module and Surveillance
Mode: FCA US says that, as the name implies, the purpose of the OPP
module when activated (i.e., put in ``Surveillance Mode'') is to
provide warning and some measure of protection for law enforcement
officers against ambush from the rear of the vehicle while parked. FCA
US states that they provided the OPP module, manufactured by
InterMotive Inc., (``InterMotive''), free of charge to Police
Departments as part of the purchase of a MY 2017-2020 Dodge Charger
Pursuit vehicle. The OPP module is a ``plug and play'' module, shipped
separately from the vehicle and installed by the Police Department or
an installer of its choice.
    When Surveillance Mode is activated, the reverse camera display
will turn on. Surveillance Mode uses the rear Park Assist system in the
Charger Pursuit vehicle. If any of the sensors detect a presence while
in Surveillance Mode, the vehicle will chime indicating which sensor
tripped, and then the OPP module will lock all the doors, roll the
driver and passenger front windows up and flash the rear lights. Again,
these actions are intended to increase an officer's situational
awareness when parked and working inside the vehicle.
    Surveillance Mode must be turned on by the driver, and it will only
engage if all of the following conditions are met:
     The vehicle ignition must be in the RUN position;
     The transmission must be in PARK;
     Vehicle speed must be zero;
     All doors must be closed;
     Service brake must not be applied; and
     The driver must choose to activate Surveillance Mode by
pressing a switch.
    If any one of these conditions is not met, then the OPP module will
not activate Surveillance Mode.
    Once Surveillance Mode is active, it will deactivate if/when any of
the following occurs:
     The vehicle ignition is switched to the OFF position;
     The driver door is opened;
     The service brake is pressed;
     The Surveillance Mode switch is pressed; or
     The Transmission is shifted out of PARK.
    Once the OPP Surveillance Mode is deactivated, all vehicle
operations return to normal function, including accurate transmission
shift position display and auto-reversing power window operation. It
should be noted that the operation of the rear windows is not affected
while Surveillance Mode is active.
    In order for the OPP module to activate the ParkView rear backup
camera, it must tell the vehicle's other computer systems that the
vehicle is in REVERSE, even though the transmission is actually in
PARK. As a result, the PRNDL display will incorrectly show ``R'' when
FMVSS No. 102 requires it to display ``P.'' As mentioned above, this
condition only exists while the OPP system is activated in Surveillance
Mode and will be immediately corrected if any of the deactivation
criteria occur, including an attempt to shift the vehicle out of PARK.
    2. Justification for Petition for a Determination of
Inconsequentiality:
    FCA US believes these technical noncompliances are inconsequential
to motor vehicle safety for the following reasons:

a. FMVSS No. 102

    When the OPP module is in Surveillance Mode, the PRNDL display
indicates the vehicle is in REVERSE while the transmission is actually
in PARK. If a driver attempts to shift the transmission, he must press
the brake pedal because of the brake shift interlock system. Once the
brake pedal is depressed, Surveillance Mode deactivates, and the
correct gear position will be immediately displayed. Further, the
driver must have parked the vehicle, left the ignition in the RUN
position, had all doors closed, and intentionally activated
Surveillance Mode.
    Surveillance Mode of the OPP module does not increase the
likelihood of shifting errors. The temporary noncompliance of
displaying an inaccurate transmission shift position in the limited
circumstances when Surveillance Mode is intentionally activated is not
likely to result in a shifting error, since Surveillance Mode
deactivates and immediately cures the technical noncompliance if the
driver attempts to shift the transmission.
    NHTSA has previously granted inconsequential treatment for FMVSS
No. 102 transmission position indication noncompliances. Examples of
the Agency granting similar inconsequentiality petitions for temporary
incorrect gear position display include:

 General Motors 53 FR 12638 (April 15, 1988)
 General Motors 58 FR 33296 (June 16, 1993)
 Nissan 64 FR 38701 (July 19, 1999)
 Workhorse Custom Chassis 70 FR 21492 (April 26, 2005)
 Honda 71 FR 34413 (June 14, 2006)
 General Motors 76 FR 73006 (November 28, 2011)
 Nissan 78 FR 59090 (September 25, 2013)
 Paccar 79 FR 17648 (March 28, 2014)
 Ford 80 FR 42604 (July 17, 2015)
 Ford 80 FR 64058 (October 22, 2015)
 General Motors 81 FR 17761 (March 30, 2016)

    FCA US believes that the noncompliance in this instance is similar
to the situation presented in Nissan's petition where Nissan explains
``that the noncompliance is that, on the affected vehicles, a unique
sequence of actions can lead the shift position indicator to
incorrectly display the shift position as required by paragraph
S<IP_ADDRESS> of FMVSS No. 102.'' See 78 FR 59090-59091 (September 25,
2013). Nissan further explained that ``[t]his issue only occurs when
the ignition is switched from ``ON'' into ``ACC'' mode

and the engine is off. Further, the vehicle cannot be restarted unless
the ignition is switched out of ``ACC'' at which point the shift
position indicator would reset and show the correct position.'' (Id.)
FCA US cited the Agency as agreeing with Nissan, that under these
``rare'' circumstances, ``the noncompliance poses little if any risk to
motor vehicle safety.'' FCA US says that similar to Nissan's case, in
the Charger Pursuit vehicles, the inaccurate transmission shift
position display occurs only when a specific set of conditions are
present after the operator intentionally activates Surveillance Mode.
The inaccurate transmission shift position display returns to the
correct position immediately upon pressing the brake, opening the
driver's door, shifting the transmission, or pressing the Surveillance
Mode switch. Importantly, the vehicle cannot be operated in the
noncompliant condition.

b. FMVSS No. 118

    When the OPP module is in Surveillance Mode, detection of a
presence at the rear of the vehicle will initiate automatic window
closure of the driver and passenger front windows. While closing, the
power-operated windows will stop when an obstruction is detected,
however, they will not reverse direction. Removal of the reverse
direction feature was a conscious design decision made by the creator
of the OPP module, InterMotive, to facilitate the purpose of the
module--the safety and protection of law enforcement officers.
    FCA US says that the regulatory history of the standard confirms
that the primary concern is the risk to children. FCA US cited the
Agency as saying, ``The Agency's experience is that children are the
group of people most likely at risk from inadvertent or unsupervised
operation of power windows.'' See 57 FR 23958 (June 5, 1992). FCA US
believes that given the police surveillance circumstances in which this
noncompliance would manifest, children are highly unlikely to be
present in the motor vehicle. FCA US says that NHTSA has previously
granted a petition for a determination of inconsequential noncompliance
based on an analysis of whether children were likely to be present in
the front seat of the noncompliant delivery trucks. FCA US cited the
Agency as saying, ``NHTSA agrees that, given the nature and intended
use of the subject vocational vehicles, it would be unlikely for
children to be placed in the front passenger seating area.'' See 81 FR
87654-87656 (December 5, 2016). FCA US believes this purpose can be
fulfilled while also protecting law enforcement officers.
    FCA US contends that successful activation of Surveillance Mode
requires a specific set of conditions. Not only must the vehicle be in
the RUN position, in PARK, with the doors closed and no application of
the service brake, the driver must choose to activate the Surveillance
Mode. When Surveillance Mode is activated, the backup camera view will
be displayed on the radio head unit. This is an immediate visual cue
that the OPP module is in Surveillance Mode. It is unlikely that
Surveillance Mode would be inadvertently activated, and even if it
were, it is easily recognizable.
    Deactivation of Surveillance Mode is easily achieved. It is much
more likely that Surveillance Mode can be inadvertently deactivated
rather than inadvertently activated. Switching the vehicle ignition to
the OFF position, opening the driver door, pressing the service brake,
shifting the transmission out of PARK, or pressing the Surveillance
Mode switch immediately restores normal vehicle functionality,
including reverse direction functionality of the driver and passenger
front power windows. Surveillance Mode cannot be latched on from key
cycle to key cycle, as a requirement for Surveillance Mode is the
ignition in the RUN position. Again, switching the vehicle ignition to
OFF deactivates Surveillance Mode.
    Purchasers of Charger Pursuit vehicles who request the OPP module
are law enforcement agencies. Officers of such law enforcement agencies
are highly trained and sophisticated vehicle operators. Law enforcement
personnel use vehicles much differently than the average vehicle owner,
and are accustomed to, if not expect, unique vehicle attributes while
engaged in law enforcement duties.
    The OPP module is a ``plug and play'' module that can be easily
removed when and if the law enforcement agency sells the vehicle into
the civilian market. FCA US acknowledges, however, that the law
enforcement agencies cannot be required to remove the OPP module from
the vehicle prior to such sale.
    Lastly, FCA US is not aware of any injuries, or customer complaints
associated with the condition.
    FCA US concludes by again contending that the subject noncompliance
is inconsequential as it relates to motor vehicle safety, and that its
petition to be exempted from providing notification of the
noncompliance, as required by 49 U.S.C. 30118, and a remedy for the
noncompliance, as required by 49 U.S.C. 30120, should be granted.
    NHTSA notes that the statutory provisions (49 U.S.C. 30118(d) and
30120(h)) that permit manufacturers to file petitions for a
determination of inconsequentiality allow NHTSA to exempt manufacturers
only from the duties found in sections 30118 and 30120, respectively,
to notify owners, purchasers, and dealers of a defect or noncompliance
and to remedy the defect or noncompliance. Therefore, any decision on
this petition only applies to the subject vehicles that FCA US no
longer controlled at the time it determined that the noncompliance
existed. However, any decision on this petition does not relieve
vehicle distributors and dealers of the prohibitions on the sale, offer
for sale, or introduction or delivery for introduction into interstate
commerce of the noncompliant vehicles under their control after FCA US
notified them that the subject noncompliance existed.

    Authority: 49 U.S.C. 30118, 30120: delegations of authority at
49 CFR 1.95 and 501.8.

Otto G. Matheke III,
Director, Office of Vehicle Safety Compliance.
[FR Doc. 2021-08447 Filed 4-22-21; 8:45 am]
BILLING CODE 4910-59-P